These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 24 cases. Edgerton N; Sirintrapun SJ; Munoz M; Chen Z; Osunkoya AO Int J Urol; 2011 Jan; 18(1):49-54. PubMed ID: 21114685 [TBL] [Abstract][Full Text] [Related]
25. [Papillary tumors of the bladder]. Franche O; Cordun G; Danila N; Antohi E J Urol Nephrol (Paris); 1969 Jun; 75(6):361-70. PubMed ID: 5345688 [No Abstract] [Full Text] [Related]
26. Papillary urothelial tumor of the bladder in a child. Waaler G; Schistad G; Serck-Hanssen A J Pediatr Surg; 1975 Oct; 10(5):841-2. PubMed ID: 1185478 [No Abstract] [Full Text] [Related]
27. Immunohistochemical expression of Ki-67, Cyclin D1, p16INK4a, and Survivin as a predictive tool for recurrence and progression-free survival in papillary urothelial bladder cancer pTa / pT1 G2 (WHO 1973). March-Villalba JA; Ramos-Soler D; Soriano-Sarrió P; Hervás-Marín D; Martínez-García L; Martínez-Jabaloyas JM Urol Oncol; 2019 Feb; 37(2):158-165. PubMed ID: 30446453 [TBL] [Abstract][Full Text] [Related]
28. Watchful waiting for low-grade Ta bladder tumours: the idea would have been unacceptable 30 years ago, but nowadays we are highly interested in the results of this study exploring it. Oosterlinck W Eur Urol; 2006 Feb; 49(2):215-6. PubMed ID: 16426733 [No Abstract] [Full Text] [Related]
29. Inverted papilloma of the urinary bladder: a report of two cases. Sullivan JJ; Watson JG; Kingston CW; Yaxley RP Aust N Z J Surg; 1971 Aug; 41(1):60-2. PubMed ID: 5286341 [No Abstract] [Full Text] [Related]
30. [Micropapillary bladder carcinoma]. Charfi S; Moussa A; Njim L; Toffahi M; Hadhri R; Mahmoudi H; Zakhama A Prog Urol; 2006 Nov; 16(5):607-9. PubMed ID: 17175962 [TBL] [Abstract][Full Text] [Related]
31. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Yin H; Leong AS Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208 [TBL] [Abstract][Full Text] [Related]
32. EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma. Schulman CC; Rozencweig M; Staquet M; Kenis Y; Sylvester R Eur Urol; 1976; 2(6):271-3. PubMed ID: 829223 [TBL] [Abstract][Full Text] [Related]
35. KL-6 is another useful marker in assessing a micropapillary pattern in carcinomas of the breast and urinary bladder, but not the colon. Ohtsuki Y; Kuroda N; Umeoka T; Watanabe R; Ochi K; Okada Y; Lee GH; Furihata M Med Mol Morphol; 2009 Jun; 42(2):123-7. PubMed ID: 19536620 [TBL] [Abstract][Full Text] [Related]
36. [Case 7. Perspectives in 2007 for bladder pathology. High-grade micropapillary urothelial carcinoma]. Compérat E Ann Pathol; 2008 Sep; 28(4):298-301. PubMed ID: 18928870 [No Abstract] [Full Text] [Related]
37. [Superficial papillary bladder cancer and carcinoma in situ]. Bandhauer K; Bischof B Helv Chir Acta; 1985 Sep; 52(3-4):467-8. PubMed ID: 4066375 [No Abstract] [Full Text] [Related]